News tagged with journal of clinical oncology
Related topics: oncology , breast cancer , patients , chemotherapy , cancer
Sentinel node biopsy safe for vulvar squamous cell cancer
(HealthDay) -- For women with squamous cell carcinoma (SCC) of the vulva, sentinel lymph node (SLN) biopsy may be safely used in place of inguinal femoral lymphadenectomy, according to research published online ...
Cancer
Jul 08, 2012 |
not rated yet |
0
Patient decision aid beneficial in papillary thyroid cancer
(HealthDay) -- Patients with early-stage papillary thyroid cancer (PTC) may benefit from the use of a patient-directed computerized decision aid (DA) to provide medical knowledge and resolve decisional conflicts ...
Cancer
Jul 06, 2012 |
not rated yet |
0
Nomogram developed to estimate early breast cancer survival
(HealthDay) -- A nomogram has been developed to predict five- and 10-year mastectomy-free survival (MFS) in older women with early breast cancer and estimate the predicted benefit of radiation therapy (RT) ...
Cancer
Jun 27, 2012 |
not rated yet |
0
Hospice visit number affects ability to die at home
(HealthDay) -- Hospice patients with cancer are more likely to be able to die in the setting of their choice if they receive at least one hospice visit per day during the first four days of hospice care, according ...
Cancer
Jun 27, 2012 |
not rated yet |
0
Tumor-Infiltrating lymphocyte grade IDs melanoma survival
(HealthDay) -- Tumor-infiltrating lymphocyte (TIL) grade is an independent predictor of melanoma-specific survival and sentinel lymph node (SLN) status in patients with localized primary cutaneous melanoma, ...
Cancer
Jun 20, 2012 |
not rated yet |
0
Hepatitis B screening before chemo deemed cost-effective
(HealthDay) -- Universal hepatitis B virus (HBV) screening before chemotherapy for lymphoma reduces costs in most settings, according to a study published online June 18 in the Journal of Clinical Oncology.
Cancer
Jun 20, 2012 |
not rated yet |
0
Germ-line <i>BRCA1/2</i> testing recommended in ovarian cancer
(HealthDay) -- Due to the potential survival and treatment response implications of BRCA mutation status, it is recommended that germ-line BRCA1/2 testing be offered to all women diagnosed with nonmucinous o ...
Cancer
Jun 19, 2012 |
not rated yet |
0
Changes in tumor size by RECIST correlate with survival
(HealthDay) -- RECIST categories used to quantify tumor changes during exposure to anticancer therapies correlate well with overall survival (OS) but reflect a more linear continuum without clear inflection ...
Cancer
Jun 13, 2012 |
not rated yet |
0
ASCO: Trametinib improves survival in metastatic melanoma
(HealthDay) -- For patients with metastatic melanoma with activating mutations in serine-threonine protein kinase B-RAF (BRAF), treatment with the oral selective MEK inhibitor trametinib is associated with ...
Cancer
Jun 05, 2012 |
not rated yet |
0
Radiation ups event-free, not overall survival in ped Hodgkin's
(HealthDay) -- For children with Hodgkin's lymphoma who respond to chemotherapy, treatment with low-dose involved-field radiation therapy (IFRT) improves event-free survival (EFS), but has no significant impact ...
Cancer
May 31, 2012 |
5 / 5 (1) |
0
Pathologic response prediction of survival aided by tumor type
(HealthDay) -- Pathologic complete response (pCR) is more highly predictive of recurrence-free survival (RFS) when specific breast cancer tumor type is factored in, according to a study published online May ...
Cancer
May 30, 2012 |
not rated yet |
0
Obesity, overweight at diagnosis ups B-cell lymphoma prognosis
(HealthDay) -- For U.S. veterans with diffuse large B-cell lymphoma (DLBCL), being overweight or obese at time of diagnosis correlates with improved survival, according to a study published online May 29 in ...
Cancer
May 30, 2012 |
not rated yet |
0
Brentuximab vedotin effective in large-cell lymphoma
(HealthDay) -- More than half of patients with relapsed or refractory systemic anaplastic large-cell lymphoma (ALCL) treated with the CD30-directed antibody-drug conjugate brentuximab vedotin achieve a complete ...
Cancer
May 24, 2012 |
not rated yet |
0
Childhood cancer scars survivors later in life
Scars left behind by childhood cancer treatments are more than skin-deep. The increased risk of disfigurement and persistent hair loss caused by childhood cancer and treatment are associated with emotional distress and reduced ...
Cancer
May 24, 2012 |
not rated yet |
0
Regorafenib active in metastatic GI stromal tumors
(HealthDay) -- Regorafenib, an inhibitor of multiple cancer-associated kinases, is active in patients with metastatic gastrointestinal stromal tumors (GIST) who have failed to respond to imatinib and sunitinib, ...
Cancer
May 23, 2012 |
not rated yet |
0
